Publication | Open Access
Phase II Study of Combination Chemotherapy with Gemcitabine and Cisplatin for Patients with Metastatic Pancreatic Cancer
12
Citations
21
References
2007
Year
The combination of gemcitabine and cisplatin administered by this schedule produced a good response rate associated with moderate but manageable toxicities in patients with metastatic pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1